retatrutide phase 2 nejm 2023 obesity trial results in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide Research Guide: What the

Patients should receive counseling from a dietician regarding the consumption of frequent small-volume nutrient meals that are low in fat and soluble fiber

doi: 10.1093/eurjpc/zwac128 21 LachGSchellekensHDinanTGCryanJF

At least, that's how I understand it." Jonathan Van Ness The Queer Eye star explained in October 2025 that they started using a GLP-1 after a health scare in 2023

Yes research indicates that up to 80% of responsive patients saw normalization of their menstrual cycles with Ozempic treatment

open-label study, there were no significant changes in visual field or OCT measures from baseline to six months in either group